Skip to content
10-Q

Quarterly Report

ICOSAVAX, INC.

0000950170-22-025032

← back to feed
Filed
Nov 14, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 7, 2022 39.9M sh
Short Term Investments Q3 2022 · Sep 30, 2022 $156.89M
Short Term Investments Q3 2022 · Dec 31, 2021 $0
Current Liabilities Q3 2022 · Sep 30, 2022 $13.03M
Current Liabilities Q3 2022 · Dec 31, 2021 $9.24M
Total Liabilities Q3 2022 · Sep 30, 2022 $18.22M
Total Liabilities Q3 2022 · Dec 31, 2021 $9.41M
Current Assets Q3 2022 · Sep 30, 2022 $228.73M
Current Assets Q3 2022 · Dec 31, 2021 $286.55M
Total Assets Q3 2022 · Sep 30, 2022 $243.88M
Total Assets Q3 2022 · Dec 31, 2021 $287.63M
Shares Diluted Q3 2022 · Sep 30, 2021 26.49M sh
Shares Diluted Q3 2022 · Sep 30, 2021 10.84M sh
Capex Q3 2022 · Sep 30, 2021 $583K
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$25.5M
Cash And Equivalents Q3 2022 · Sep 30, 2021 $293.92M
Cash And Equivalents Q3 2022 · Dec 31, 2020 $15.5M
Stockholders Equity Q3 2022 · Sep 30, 2021 $292.44M
Stockholders Equity Q3 2022 · Jun 30, 2021 −$39.3M
Stockholders Equity Q3 2022 · Mar 31, 2021 −$32.19M
Stockholders Equity Q3 2022 · Dec 31, 2020 −$26.7M
Eps Diluted Q3 2022 · Sep 30, 2021 −$1.30
Eps Diluted Q3 2022 · Sep 30, 2021 −$4.50
Eps Basic Q3 2022 · Sep 30, 2021 −$1.30
Eps Basic Q3 2022 · Sep 30, 2021 −$4.50
Sga Expense Q3 2022 · Sep 30, 2021 $25.36M
Sga Expense Q3 2022 · Sep 30, 2021 $28.67M
Rd Expense Q3 2022 · Sep 30, 2021 $10.88M
Rd Expense Q3 2022 · Sep 30, 2021 $24.71M
Net Income Q3 2022 · Sep 30, 2021 −$34.39M
Net Income Q3 2022 · Sep 30, 2021 −$48.79M
Net Income Q3 2022 · Jun 30, 2021 −$8.55M
Net Income Q3 2022 · Mar 31, 2021 −$5.85M
Operating Income Q3 2022 · Sep 30, 2021 −$34.41M
Operating Income Q3 2022 · Sep 30, 2021 −$47.65M